Bausch Health Companies Inc.

BHC-T

TSE:BHC

21.99
1.21 (5.82%)
Bausch Health Companies Inc. is a multinational specialty pharmaceutical company based in Laval, Canada.
More at Wikipedia

Analysis and Opinions about BHC-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
April 1, 2020
The old Valent Pharmaceutical company. When it became over-levered it struggled. He thinks there are far better opportunities in the health care space.
Show full opinionHide full opinion
The old Valent Pharmaceutical company. When it became over-levered it struggled. He thinks there are far better opportunities in the health care space.
BUY WEAKNESS
BUY WEAKNESS
February 27, 2020
He likes and owns it. It is basically the old broken valiant. He likes the space and he likes the big time drugs. These stocks offer incredible value. His model price is $72.41, 122% upside. Buy it when it comes down again. Buy half on the way in.
Show full opinionHide full opinion
He likes and owns it. It is basically the old broken valiant. He likes the space and he likes the big time drugs. These stocks offer incredible value. His model price is $72.41, 122% upside. Buy it when it comes down again. Buy half on the way in.
DON'T BUY
DON'T BUY
January 17, 2020
He gives managements kudos for restructuring the business. They are still heavily indebted. He is looking for valuation with consistent cashflow which this is not. It's not the type of company he looks at.
Show full opinionHide full opinion
He gives managements kudos for restructuring the business. They are still heavily indebted. He is looking for valuation with consistent cashflow which this is not. It's not the type of company he looks at.
WATCH
WATCH
November 19, 2019
Kudos to the management for selling off businesses and paying down debt. It may be something investor should look at again.
Show full opinionHide full opinion
Kudos to the management for selling off businesses and paying down debt. It may be something investor should look at again.
BUY
BUY
November 8, 2019
If it can continue on volume, it looks very positive. It has built a nice base and it’s worthy of a buy. Support should be around $27. He would aim for the 100 day moving average.
Show full opinionHide full opinion
If it can continue on volume, it looks very positive. It has built a nice base and it’s worthy of a buy. Support should be around $27. He would aim for the 100 day moving average.
BUY
BUY
November 4, 2019
A covered call He likes covered calls and you can do it with BHC. Write them and take the premium here. BHC has been rangebound, but demographics favour health stocks. However, governments will limit pricing of health services.
Show full opinionHide full opinion
A covered call He likes covered calls and you can do it with BHC. Write them and take the premium here. BHC has been rangebound, but demographics favour health stocks. However, governments will limit pricing of health services.
DON'T BUY
DON'T BUY
October 8, 2019
There's too much debt and not enough growth to pay it off. The stock has sold off as their generic products face new competition.
Show full opinionHide full opinion
There's too much debt and not enough growth to pay it off. The stock has sold off as their generic products face new competition.
COMMENT
COMMENT
August 2, 2019
They still only have a couple products that are growing. Other drugs are in their infancy or not growing. If they're not able to cover debt with free cashflow, you won't see any dividends.
Show full opinionHide full opinion
They still only have a couple products that are growing. Other drugs are in their infancy or not growing. If they're not able to cover debt with free cashflow, you won't see any dividends.
BUY
BUY
July 11, 2019
After a stunning fall from grace, there's been a stunning recovery. FMV is 127% higher than it's currently trading, and it's been there before. Looks like a resurrection.
Show full opinionHide full opinion
After a stunning fall from grace, there's been a stunning recovery. FMV is 127% higher than it's currently trading, and it's been there before. Looks like a resurrection.
DON'T BUY
DON'T BUY
May 2, 2019
There are better opportunities out there. They meet his criteria except for their debt levels.
Show full opinionHide full opinion
There are better opportunities out there. They meet his criteria except for their debt levels.
TOP PICK
TOP PICK
November 30, 2018
He likes it because nobody likes it. It is former Valiant Pharmaceuticals and trades at 6 times cash-flow. He encourages investors to look beyond its checkered past. It has high quality recurring cash-flows in the contact lens division. Every division is growing organically. It does have a high debt load, but the trajectory of cash flow will elevate that risk. Yield 0%. (Analysts’ price target is $35.39)
Show full opinionHide full opinion
He likes it because nobody likes it. It is former Valiant Pharmaceuticals and trades at 6 times cash-flow. He encourages investors to look beyond its checkered past. It has high quality recurring cash-flows in the contact lens division. Every division is growing organically. It does have a high debt load, but the trajectory of cash flow will elevate that risk. Yield 0%. (Analysts’ price target is $35.39)
COMMENT
COMMENT
October 17, 2018

It's the old Valeant. It has a future, cleaned up their act, but too much debt. Stable now, so maybe good for the long-term, certainly better than the Valeant days.

Show full opinionHide full opinion

It's the old Valeant. It has a future, cleaned up their act, but too much debt. Stable now, so maybe good for the long-term, certainly better than the Valeant days.

Showing 1 to 12 of 12 entries
  • «
  • 1
  • »

Bausch Health Companies Inc.(BHC-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 4

Total Signals / Votes : 8

Stockchase rating for Bausch Health Companies Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Bausch Health Companies Inc.(BHC-T) Frequently Asked Questions

What is Bausch Health Companies Inc. stock symbol?

Bausch Health Companies Inc. is a Canadian stock, trading under the symbol BHC-T on the Toronto Stock Exchange (BHC-CT). It is usually referred to as TSX:BHC or BHC-T

Is Bausch Health Companies Inc. a buy or a sell?

In the last year, 8 stock analysts published opinions about BHC-T. 4 analysts recommended to BUY the stock. 4 analysts recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for Bausch Health Companies Inc..

Is Bausch Health Companies Inc. a good investment or a top pick?

Bausch Health Companies Inc. was recommended as a Top Pick by Brett Girard, CPA, CA, CFA on 2020-04-01. Read the latest stock experts ratings for Bausch Health Companies Inc..

Why is Bausch Health Companies Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Bausch Health Companies Inc. worth watching?

8 stock analysts on Stockchase covered Bausch Health Companies Inc. In the last year. It is a trending stock that is worth watching.

What is Bausch Health Companies Inc. stock price?

On 2020-04-08, Bausch Health Companies Inc. (BHC-T) stock closed at a price of $21.99.